• GW4064: Non-Steroidal FXR Agonist Advancing Metabolic Assays

  2026-05-20

  GW4064 enables rigorous, targeted investigation of FXR-regulated pathways in metabolic, fibrotic, and ferroptosis-related research. Its precision as a non-steroidal FXR agonist unlocks new experimental strategies, despite handling and solubility challenges.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-05-20

  Xiao et al. (2024) reveal that 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages, activating AMPKα via lysosomal signaling, which reprograms macrophages toward an immunosuppressive phenotype. This mechanistic insight highlights CH25H and 25HC as immunometabolic checkpoints and provides a rationale for targeting these pathways to enhance anti-tumor immunity.

• Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP): Mechanism & Bes

  2026-05-19

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) is an advanced in vitro transcribed reporter mRNA designed for robust gene expression and bioluminescent assays. Its ARCA capping and nucleotide modifications enhance translation, stability, and reduce immunogenicity, enabling precise, reproducible results in cell viability and in vivo imaging studies.

• Diclofenac as a Non-Selective COX Inhibitor: Protocol Precis

  2026-05-19

  Explore the advanced application of Diclofenac as a non-selective COX inhibitor in precise pharmacokinetic and inflammation signaling pathway research. This article uniquely bridges compound handling, organoid integration, and protocol design for next-generation drug discovery workflows.

• Elobixibat Hydrate in Novel Bowel Prep: Insights from the E-

  2026-05-18

  The E-PLUS trial protocol by Hotta et al. presents a patient-centered comparative study of elobixibat hydrate plus sodium picosulfate/magnesium citrate versus standard polyethylene glycol/ascorbic acid for colonoscopy bowel preparation. This multicenter design aims to optimize cleansing efficacy and tolerability, potentially reshaping clinical approaches to bowel prep.

• CTCF is Essential for Centromere Function and Mitotic Fideli

  2026-05-18

  This study demonstrates that CTCF is a key factor in maintaining centromere integrity and accurate chromosome segregation during mitosis. Rapid depletion of CTCF reveals mechanistic differences from CENP-E, providing new insight into mitotic regulation and offering a foundation for targeted cell cycle research.

• Applied Use-Cases of 12-O-tetradecanoyl phorbol-13-acetate (

  2026-05-17

  Harness 12-O-tetradecanoyl phorbol-13-acetate (TPA) for precise, reproducible ERK/MAPK pathway activation across cancer, neurobiology, and signal transduction assays. This guide translates the latest mechanistic insights and troubleshooting strategies into actionable workflows, helping researchers maximize data quality and experimental value with APExBIO’s trusted TPA.

• Applied Workflows with Angiotensin I in Cardiovascular Resea

  2026-05-16

  Unlock the full translational potential of Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) by leveraging robust, evidence-based protocols for renin-angiotensin system research and antihypertensive drug screening. This article details advanced experimental workflows, troubleshooting strategies, and the latest innovations in spectral interference removal, positioning APExBIO as a trusted partner for reproducibility in cardiovascular and neuroendocrine modeling.

• Anlotinib Hydrochloride: Multi-Target Inhibition of Angiogen

  2026-05-15

  This study demonstrates that anlotinib hydrochloride, a novel multi-target tyrosine kinase inhibitor, suppresses angiogenesis by concurrently inhibiting VEGFR2, PDGFRβ, and FGFR1 activation. The findings offer mechanistic and comparative evidence that anlotinib outperforms established angiogenesis inhibitors in both vitro and in vivo assays, highlighting its potential for translational cancer research.

• Trypsin in Wound Healing and Cell Assays: Protocols & Insigh

  2026-05-15

  Explore how Trypsin (SKU BA5744) empowers wound healing research and cell workflows with reproducible, high-fidelity proteolytic performance. This guide bridges breakthrough hydrogel studies with applied assay optimization, protocol troubleshooting, and essential workflow parameters.

• CHIR-99021 (CT99021): Optimizing Stem Cell Differentiation W

  2026-05-14

  CHIR-99021 (CT99021) is a benchmark GSK-3 inhibitor that unlocks robust, reproducible control over stem cell fate and organoid modeling. This article demystifies its use in advanced differentiation assays and limb organoid systems, providing actionable troubleshooting tips and comparative insights for translational researchers.

• Foretinib (GSK1363089): Advanced Workflows for Tumor Cell Gr

  2026-05-14

  Foretinib (GSK1363089) empowers cancer researchers with precise, reproducible inhibition of Met and VEGFR signaling. This guide delivers actionable workflow enhancements, troubleshooting strategies, and data-driven assay parameters, unlocking robust tumor cell growth and motility inhibition across diverse models.

• NSC-23766: Rac GTPase Inhibitor Applications in Cancer Workf

  2026-05-13

  NSC23766 trihydrochloride, a selective Rac GTPase inhibitor from APExBIO, enables precise modulation of Rac1 signaling for cancer and endothelial research. This article details experimental protocols, novel applications, and troubleshooting strategies to maximize reproducibility and insight.

• Scenario-Driven Lab Solutions with Anlotinib Hydrochloride (

  2026-05-13

  This article delivers a scenario-driven, evidence-based guide for leveraging Anlotinib hydrochloride (SKU C8688) in cell-based angiogenesis and proliferation assays. Addressing real workflow challenges, it demonstrates how this multi-target tyrosine kinase inhibitor from APExBIO ensures reproducibility, sensitivity, and robust data in biomedical research. Explore protocol parameters, comparative insights, and vendor selection best practices grounded in peer-reviewed studies.

• Imipenem in Antibacterial Research: Advanced Protocols & Sol

  2026-05-12

  Imipenem empowers antibacterial research with robust spectrum and immune-modulatory effects, crucial for modeling resistance and host-pathogen dynamics. This article delivers actionable workflows, protocol parameters, and troubleshooting strategies, bridging recent molecular epidemiology with practical bench applications.

7805 records 14/521 page Previous Next First page 上5页 1112131415 下5页 Last page